Medical Study Reveals Why Older Adults Choose Cannabis Edibles
A recent medical study examined cannabis edible use among older adults, revealing therapeutic rather than recreational motivations. Older adults cannabis edibles consumption focuses on pain management and mental health symptom relief when traditional…
Cannabis Edibles for Older Adults Show Therapeutic Promise in New Study
A recent medical study reveals that cannabis edibles older adults consume are primarily used for therapeutic rather than recreational purposes. The research shows seniors turn to edibles for managing chronic pain, anxiety, and depression with genuine…
Cannabis Schedule III Rescheduling Impact on Medical Research and Patients
The potential rescheduling of cannabis from Schedule I to Schedule III represents a significant regulatory shift that could reduce research barriers and accelerate clinical investigation. Cannabis schedule III rescheduling would lower DEA registration…
Cannabis Terpenes Explained: Why They Matter When You Shop at a Dispensary
Cannabis terpenes dispensary shopping has become increasingly important as patients seek strains based on aromatic compounds beyond THC and CBD. Terpenes like myrcene, limonene, and pinene have documented pharmacological properties that may influence…
Cannabis Edibles and Alcohol Create Synergistic Driving Impairment
A recent study reveals that cannabis edibles and alcohol produce synergistic impairment that exceeds the combined effects of either substance used alone. This finding has significant implications for patient counseling, as clinicians must warn patients…
Fewer Than 1 in 5 Older Adults Discuss Cannabis Use With Clinicians
A recent study reveals that fewer than 20% of older adults disclose their cannabis use to healthcare providers, creating a significant communication gap. This silence prevents clinicians from assessing drug interactions and monitoring adverse effects in…
Fewer than 1 in 5 Older Adults Discuss Cannabis Use with Clinicians
A recent study reveals that fewer than 20% of older adults discuss cannabis use with their healthcare providers, creating a significant older adults cannabis communication gap. This lack of disclosure puts seniors at risk for dangerous drug interactions…
FDA Grants Cannabis Extract VER-01 Breakthrough Therapy Status for Pain
The FDA has awarded Breakthrough Therapy Designation to VER-01, a pharmaceutical-grade cannabis extract for chronic low back pain. This marks the first FDA breakthrough therapy cannabis designation for pain treatment, backed by Phase 3 trials showing…
What a Large 2026 Study Reveals About GLP-1 Medications and Hair Loss
Semaglutide hair loss risk emerged as a significant signal in a large propensity-matched cohort study involving hundreds of thousands of patients. Researchers found higher rates of nonscarring hair loss among semaglutide and tirzepatide users compared…
GLP-1 Drugs, Semaglutide, and the Future of Alcohol Addiction Treatment
GLP-1 receptor agonists for alcohol use disorder are attracting growing scientific interest as potential tools for reducing alcohol consumption and relapse risk. This review examines preclinical evidence, observational studies, and randomized controlled…